NCT03314935 2025-08-12A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid TumorsIncyte CorporationPhase 1/2 Completed149 enrolled 35 charts
NCT03197584 2025-02-21QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) TherapyImmunityBio, Inc.Phase 1/2 Withdrawn